Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

Angelis Konstantinopoulos; Konstantinos Giannitsas; Spiros Raptis; Petros Perimenis

首页> 外文期刊>Drug Target Insights >Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

【24h】

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

机译：内皮功能障碍，勃起功能障碍和磷酸二酯酶5抑制剂。当前数据和未来展望的更新

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Endothelial dysfunction is a pathological entity that multiply affects the health status. Erectile dysfunction is being recognized as a condition that is strongly interrelated with endothelial dysfunction, being a vascular event itself. Oral pharmacotherapy for erectile dysfunction has provided us with a new armamentarium on this condition. Phosphodiesterase 5 inhibitors have been investigated and proved useful in clinical practice for erectile dysfunction but in addition to this, the results seem promising of a benefi cial effect on endothelial dysfunction, as well.

机译：内皮功能障碍是一种病理性实体，会倍增影响健康状况。勃起功能障碍被认为是与内皮功能障碍密切相关的疾病，血管内皮本身就是血管事件。口服药物治疗勃起功能障碍已为我们提供了一种在这种情况下的新武器库。磷酸二酯酶5抑制剂已被研究并证明可用于勃起功能障碍的临床实践，但除此之外，该结果似乎也有望对内皮功能障碍产生有益作用。

著录项

来源
《Drug Target Insights》 |2007年第2期|共7页
作者
Angelis Konstantinopoulos; Konstantinos Giannitsas; Spiros Raptis; Petros Perimenis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors. [J] . Hartmut Porst, Gerald B Brock, Krzysztof Kula, Journal of Andrology . 2012,第6期

机译：每日一次他达拉非对勃起功能障碍但未使用过磷酸二酯酶5型抑制剂的男性的治疗满意度，社会心理结局，自发勃起和内皮功能测定的影响。
2. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. [J] . Sommer F, Schulze W World journal of urology . 2005,第6期

机译：用磷酸二酯酶5抑制剂通过内皮修复治疗勃起功能障碍。
3. Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 Inhibitors. Review of the Literature [J] . LombardiG., NelliF., CelsoM., The journal of sexual medicine . 2012,第4期

机译：用口服磷酸二酯酶5型抑制剂治疗勃起功能障碍和中枢神经系统疾病。文献回顾
4. Endothelial dysfunction, platelets hyperactivity and oxidative stress in correlation with outcomes and left ventricular systolic dysfunction in acute coronary syndromes [C] . Bobescu E., Radoi M., Datcu G., International Congress on Coronary Artery Disease . 2011

机译：内皮功能障碍，血小板多动和氧化应激与急性冠状动脉综合征中的结果和左心室收缩功能障碍
5. The relationship between erectile function, traditional masculine ideology, and marital satisfaction among younger and older Taiwanese men with erectile dysfunction. [D] . Wang, Paul Song Cherng. 2008

机译：台湾年轻和较老的勃起功能障碍男性的勃起功能，传统男性意识形态和婚姻满意度之间的关系。
6. Endothelial Dysfunction Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives [O] . Angelis Konstantinopoulos, Konstantinos Giannitsas, Spiros Raptis, 2007

机译：内皮功能障碍勃起功能障碍和磷酸二酯酶5抑制剂。当前数据和未来展望的更新
7. Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives [O] . Angelis Konstantinopoulos, Konstantinos Giannitsas, Spiros Raptis, 2007

机译：内皮功能障碍，勃起功能障碍和磷酸二酯酶5抑制剂。更新当前数据和未来前景

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives

摘要

著录项

相似文献

相关主题

期刊订阅